Based in Sweden, Epigenica is a startup. Brouky records 1 investor associated with the company.
Epigenica develops multiplexed chromatin profiling technology enabling high-throughput, quantitative analysis of epigenetic marks such as DNA methylation and histone modifications from low input material to support biomedical research and precision medicine.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.